TIP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Taxol-Ifosfamide-Platinol Regimen; TIP Regimen
Overview
Overview
TIP regimen refers to a regimen consisting of paclitaxel, ifosfamide, mesna and cisplatin used for the treatment of advanced-stage testicular cancer[1]; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer.[2]
Regimen
Regimen
TTaxol (paclitaxel)
IIfosfamide
PPlatinol (cisplatin)
Indications
Indications
References
References
- ↑ 1.0 1.1 Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J; et al. (2005). “Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors”. J Clin Oncol. 23 (27): 6549–55. doi:10.1200/JCO.2005.19.638. PMID 16170162.
- ↑ 2.0 2.1 Shin DM (2000). “Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck”. Semin Oncol. 27 (1 Suppl 1): 36–40. PMID 10697043.
- ↑ “NCI Thesaurus”.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH